Moderna, Inc. (MRNA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 151.01 |
| Open | 152.00 |
| Bid | 148.54 x 100 |
| Ask | 148.74 x 200 |
| Day's range | 143.77 - 152.28 |
| 52-week range | 62.55 - 170.47 |
| Volume | |
| Avg. volume | 4,011,057 |
| Market cap | 56.946B |
| Beta (5Y monthly) | 1.54 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -15.60 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 143.52 |
Fool.co.uk1 exciting growth stock to buy for the long run in June
Shares of Moderna have more than doubled since mid-November. Here's why this writer thinks it's now a stock to buy for his portfolio. The post 1 exciting growth stock to buy for the long run in June appeared first on The Motley Fool UK.
ZacksModerna (MRNA) Stock Sinks As Market Gains: Here's Why
In the latest trading session, Moderna (MRNA) closed at $148.59, marking a -1.6% move from the previous day.
Investor's Business DailyModerna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
Moderna said Monday its Covid/flu vaccine topped rivals from GSK and Sanofi, and its own Spikevax shot. But Moderna stock fell.
© 2024 Yahoo. All rights reserved.